Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$7.24 - $11.2 $726,172 - $1.12 Million
-100,300 Closed
0 $0
Q4 2020

Feb 02, 2021

SELL
$2.36 - $9.99 $22,391 - $94,785
-9,488 Reduced 8.64%
100,300 $868,000
Q2 2020

Aug 12, 2020

BUY
$3.01 - $4.02 $41,802 - $55,829
13,888 Added 14.48%
109,788 $367,000
Q1 2020

May 12, 2020

SELL
$2.58 - $4.58 $6,450 - $11,450
-2,500 Reduced 2.54%
95,900 $314,000
Q3 2017

Nov 15, 2017

BUY
$1.2 - $2.84 $118,080 - $279,456
98,400
98,400 $261,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $46.5M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.